A nano-cap struggles to ride the IPO wave; Seattle Genetics gets a GSK milestone
The last 8 months have seen an unprecedented spate of massive biotech IPOs. Companies have been able to raise well over $200 million despite being …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
